» Articles » PMID: 26681320

Peripheral Loss of CD8(+) CD161(++) TCRVα7·2(+) Mucosal-associated Invariant T Cells in Chronic Hepatitis C Virus-infected Patients

Overview
Publisher Wiley
Specialty General Medicine
Date 2015 Dec 19
PMID 26681320
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mucosal-associated invariant T (MAIT) cells play an important role in innate host defence. MAIT cells appear to undergo exhaustion and are functionally weakened in chronic viral infections. However, their role in chronic hepatitis C virus (HCV) infection remains unclear.

Materials And Methods: We investigated the frequency of CD8(+) CD161(++) TCR Vα7.2(+) MAIT cells in a cross-sectional cohort of chronic HCV-infected patients (n = 25) and healthy controls (n = 25). Peripheral blood mononuclear cells were investigated for circulating MAIT cell frequency, liver-homing (CCR5 and CD103), biomarkers of immune exhaustion (PD-1, TIM-3 and CTLA-4), chronic immune activation (CD38 and HLA-DR), and immunosenescence (CD57) by flow cytometry.

Results: The frequency of MAIT cells was significantly decreased, and increased signs of immune exhaustion and chronic immune activation were clearly evident on MAIT cells of HCV-infected patients. Decrease of CCR5 on circulating MAIT cells is suggestive of their peripheral loss in chronic HCV-infected patients. MAIT cells also showed significantly increased levels of HLA-DR, CD38, PD-1, TIM-3 and CTLA-4, besides CD57 in chronic HCV disease.

Conclusions: Immune exhaustion and senescence of CD8(+) CD161(++) TCR Vα7.2(+) MAIT cells could contribute to diminished innate defence attributes likely facilitating viral persistence and HCV disease progression.

Citing Articles

The Role of Mucosal-Associated Invariant T Cells in Viral Infections and Their Function in Vaccine Development.

Sugimoto C, Wakao H Vaccines (Basel). 2025; 13(2).

PMID: 40006702 PMC: 11860804. DOI: 10.3390/vaccines13020155.


A Comprehensive Investigation of Stimulatory Agents on MAIT and Vα7.2+/CD161- T Cell Response and Effects of Immunomodulatory Drugs.

Singh P, Szaraz-Szeles M, Barath S, Hevessy Z Int J Mol Sci. 2024; 25(11).

PMID: 38892082 PMC: 11172258. DOI: 10.3390/ijms25115895.


Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.

Bengtsson B, Maucourant C, Sandberg J, Bjorkstrom N, Hagstrom H PLoS One. 2024; 19(5):e0294695.

PMID: 38691552 PMC: 11062522. DOI: 10.1371/journal.pone.0294695.


Investigating Vα7.2/CD161 T Cell and MAIT Cell Profiles Using Flow Cytometry in Healthy Subjects and Subjects with Atopic Dermatitis.

Singh P, Gaspar K, Szegedi A, Sajtos L, Barath S, Hevessy Z Int J Mol Sci. 2024; 25(6).

PMID: 38542456 PMC: 10970526. DOI: 10.3390/ijms25063486.


Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients' PBMCs.

Ibrahim I, Ali O, El-Sahar A, Elrefaei M, El-Sheikh N J Clin Exp Hepatol. 2023; 13(6):1008-1016.

PMID: 37975051 PMC: 10643511. DOI: 10.1016/j.jceh.2023.06.004.